Johnson & Johnson CEO: Our aim is to become the number one oncology company
Jun 3, 2024
CNBC’s Angelica Peebles and Johnson & Johnson CEO Joaquin Duato join 'Squawk on the Street' to discuss the company's goals in oncology, the future of cancer treatments, state of the talc lawsuits, drug price negotiations, and more.
